October 16th (Eastern Time) - $Kintara Therapeutics (KTRA.US)$ is about to implement a 1-for-35 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from October 18th, 2024.
$Kintara Therapeutics (KTRA.US)$ rose 14.7% and closed at $0.227 on October 15th with a turnover of $1.07 million. $Kintara Therapeutics (KTRA.US)$ now has a total market capitalization of $12.63 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.